{"id":106748,"date":"2020-05-07T19:08:30","date_gmt":"2020-05-08T02:08:30","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2020\/05\/moderna-shares-surge-after-fda-approves-coronavirus-vaccine-for-phase-2-trial"},"modified":"2020-05-07T19:08:30","modified_gmt":"2020-05-08T02:08:30","slug":"moderna-shares-surge-after-fda-approves-coronavirus-vaccine-for-phase-2-trial","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2020\/05\/moderna-shares-surge-after-fda-approves-coronavirus-vaccine-for-phase-2-trial","title":{"rendered":"Moderna shares surge after FDA approves coronavirus vaccine for phase 2 trial"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/moderna-shares-surge-after-fda-approves-coronavirus-vaccine-for-phase-2-trial.jpg\"><\/a><\/p>\n<p>The company said it expects to \u201cincur significant expenses this year\u201d related to the development of and manufacturing of its potential vaccine. However, it added that it expects \u201ca close matching of expenses and reimbursements for those expenses\u201d from its award by the Biomedical Advanced Research and Development Authority.<\/p>\n<p>BARDA, which is a part of the Department of Health and Human Services, <a href=\"https:\/\/www.cnbc.com\/2020\/04\/17\/moderna-soars-on-483-million-in-funding-for-coronavirus-vaccine.html\">last month warded Moderna up to $483 million in funding to accelerate development of the Covid-19 vaccine candidate<\/a>.<\/p>\n<p>The race to develop anything to fight the coronavirus is intensely competitive and investors are watching closely for signs of progress on treatments and vaccines. Moderna, as well as other companies in the race, is ramping up manufacturing ahead of approval so that it can rapidly distribute doses if their candidate proves effective against the virus and safe for humans.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The company said it expects to \u201cincur significant expenses this year\u201d related to the development of and manufacturing of its potential vaccine. However, it added that it expects \u201ca close matching of expenses and reimbursements for those expenses\u201d from its award by the Biomedical Advanced Research and Development Authority. BARDA, which is a part of [\u2026]<\/p>\n","protected":false},"author":513,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-106748","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/106748","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/513"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=106748"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/106748\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=106748"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=106748"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=106748"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}